Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1670746

	registered interest
	date	17/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of (a) updates to the programme manual used by the National Institute of Health and Care Excellence including Rapid Access to Managed Access and (b) the introduction of the Innovative Medicines Fund.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	2397
	answer	answer is ministerial correction date of answer 22/11/2023 answer text <p>The Government is committed to supporting rapid patient access to effective new medicines in a way that is fair to all parties and represents value to the National Health Service. The National Institute for Health and Care Excellence (NICE) plays an important role in supporting patient access to effective new medicines and is able to recommend most new medicines for use in the NHS. Where there is too much clinical uncertainty for NICE to be able to recommend routine funding, it is able to recommend medicines for use through the Cancer Drugs Fund or Innovative Medicines Fund which make promising medicines available to patients while further real-world evidence is collected to inform a final NICE recommendation.</p><p>NICE is responsible for the methods and processes it uses in the evaluation of new medicines and the changes that it has recently made to its evaluation processes will enable it to produce faster guidance on simpler, low-risk treatments. NICE and NHS England are exploring options for rapid entry to managed access (REMA) that build on the experience of the Cancer Drugs Fund and Innovative Medicines Fund to support managed access to medicines. NICE has not yet made any changes to its health technology evaluation manual related to REMA.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/11/2023 15:53:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3960 label Biography information for Henry Smith

1669201

	registered interest
	date	10/11/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Innovative Medicines Fund: Gene Therapies
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the Innovative Medicines Fund in increasing access to gene therapies.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	1326
	answer	answer is ministerial correction date of answer 16/11/2023 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service in England on whether all new licensed medicines represent a clinically effective and cost-effective use of NHS resources. NICE has been able to recommend several gene therapies for routine funding and they are now routinely available to NHS patients in line with NICE’s recommendations. No gene therapies have been recommended for use through the Innovative Medicines Fund and NICE continues to consider the suitability of medicines for the Fund with individual companies.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 16/11/2023 17:26:10 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3960 label Biography information for Henry Smith

1665400

	registered interest
	date	17/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Heart Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the recommendations of the British Society for Echocardiography made in its report entitled The UK Echocardiography Workforce published in June 2023, whether his Department is taking steps to help ensure that the NHS retains a sufficient number of experienced echocardiographers to train new recruits.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	202955
	answer	answer is ministerial correction date of answer 20/10/2023 answer text <p>NHS England has developed a new fast-track echocardiography training scheme, which has led to 150 additional echocardiographers with further support being available in 2023/24.</p><p>More generally, the NHS People Plan and the People Promise set out a comprehensive range of actions to improve staff retention. They provide a strong focus on creating a more modern, compassionate and inclusive culture in the National Health Service by strengthening health and wellbeing, equality and diversity, culture and leadership and flexible working.</p><p> </p><p>NHS priorities and operational planning guidance 23/24 has asked systems to refresh their 2022/23 whole system workforce plans to improve staff retention through a systematic focus on all elements of the NHS People Promise.  Staff wellbeing should be strategically aligned with elective recovery plans, including workforce demand and capacity planning.  In addition, the NHS Retention Programme is continuously seeking to understand why staff leave, resulting in targeted interventions to support staff to stay whilst keeping them well.</p><p> </p><p>The Long Term Workforce Plan builds on the People Plan and sets out how to improve culture and leadership to ensure that up to 130,000 fewer staff leave the NHS over the next 15 years. This includes: implementing actions from the NHS People Plan that have been shown to be successful; and implementing plans to improve flexible opportunities for prospective retirees and delivering the actions needed to modernise the NHS pension scheme.</p><p> </p><p>These interventions apply across staff groups, including echocardiographers.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/10/2023 09:37:50 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith

1658372

	registered interest
	date	05/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy: Crawley
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many radiotherapy LINAC machines will be over the recommended 10-year lifespan by the end of (a) 2023, (b) 2024, and (c) 2025 in Crawley constituency.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	197766
	answer	answer is ministerial correction date of answer 12/09/2023 answer text <p>Data on radiotherapy linear accelerator (LINAC) machines is not held at constituency level. Since April 2022, the responsibility for investing in new radiotherapy machines sits with local systems. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the National Health Service between 2022 and 2025.</p><p>Recent Capital Planning Guidance sets out the expectation that the majority of radiotherapy equipment, particularly LINAC machines, will need to be replaced at ten years of age, to make progress on Long Term Plan priorities. The guidance states that integrated care systems (ICSs) need to develop replacement plans as part of their multi-year capital plans, in partnership with specialised commissioners, Cancer Alliances and Radiotherapy Operational Delivery Networks, based on an assessment of equipment age, capacity and demand, opportunities to improve access, and service risk.</p> answering member constituency Colchester answering member printed Will Quince question first answered 12/09/2023 14:57:36 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith

1658373

	registered interest
	date	05/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to devolve any aspect of radiotherapy commissioning to integrated care boards in (a) Crawley constituency and (b) England; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	197767
	answer	answer is ministerial correction date of answer 12/09/2023 answer text <p>NHS England’s National Moderation Panel will determine how many integrated care boards (ICBs) will take on responsibility for specialised commissioning in October 2023. Following this moderation process, recommendations will be taken to the NHS England Board for final decisions in December 2023, before new arrangements go live from April 2024.</p><p>This process will consider the delegation of radiotherapy commissioning for ICBs across England including across the Crawley constituency.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 12/09/2023 13:49:15 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1655923

	registered interest
	date	01/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Defibrillators
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce economic barriers to accessing defibrillators.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	196006
	answer	answer is ministerial correction date of answer 06/09/2023 answer text <p>The Government has agreed to provide funding of £1 million to design a grant scheme for the expansion of automated external defibrillators (AEDs) that expands the number and accessibility of publicly supported access to defibrillators.</p><p>Applicants will be asked to demonstrate that defibrillators will be placed in areas where they are most needed, such as places with high footfall, longer emergency medical response times and deprived areas</p><p><br> No assessment has been made of the potential fiscal impact of increasing the number of AEDs available to the public on healthcare services. The number of instances of sudden cardiac arrest that have occurred outside of hospitals in the last five years is not available centrally.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 196007 196008 question first answered 06/09/2023 15:51:09 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith

1655924

	registered interest
	date	01/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Defibrillators
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential fiscal impact of increasing the number of Automated External Defibrillators available to the public on healthcare services.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	196007
	answer	answer is ministerial correction date of answer 06/09/2023 answer text <p>The Government has agreed to provide funding of £1 million to design a grant scheme for the expansion of automated external defibrillators (AEDs) that expands the number and accessibility of publicly supported access to defibrillators.</p><p>Applicants will be asked to demonstrate that defibrillators will be placed in areas where they are most needed, such as places with high footfall, longer emergency medical response times and deprived areas</p><p><br> No assessment has been made of the potential fiscal impact of increasing the number of AEDs available to the public on healthcare services. The number of instances of sudden cardiac arrest that have occurred outside of hospitals in the last five years is not available centrally.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 196006 196008 question first answered 06/09/2023 15:51:09 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith

1655925

	registered interest
	date	01/09/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Heart Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many instances of sudden cardiac arrest have occurred outside of hospitals in the last five years.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	196008
	answer	answer is ministerial correction date of answer 06/09/2023 answer text <p>The Government has agreed to provide funding of £1 million to design a grant scheme for the expansion of automated external defibrillators (AEDs) that expands the number and accessibility of publicly supported access to defibrillators.</p><p>Applicants will be asked to demonstrate that defibrillators will be placed in areas where they are most needed, such as places with high footfall, longer emergency medical response times and deprived areas</p><p><br> No assessment has been made of the potential fiscal impact of increasing the number of AEDs available to the public on healthcare services. The number of instances of sudden cardiac arrest that have occurred outside of hospitals in the last five years is not available centrally.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 196006 196007 question first answered 06/09/2023 15:51:09 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith

1643069

	registered interest
	date	08/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer and Radiology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has made recent representations made to (a) the Chancellor of the Exchequer and (b) NHS England on investment in the clinical (i) radiology and (ii) oncology workforce.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	188505
	answer	answer is ministerial correction date of answer 14/06/2023 answer text <p>The Secretary of State for Health and Social Care meets regularly with other Cabinet colleagues and with NHS England to discuss issues relating to the National Health Service workforce.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 14/06/2023 14:00:35 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1628301

	registered interest
	date	16/05/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Advanced Therapy Medicinal Products
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reviewing the way the National Institute for Health and Care Excellence and NHS England evaluate and adopt Advanced Therapy Medicinal Products as technologies with the potential to deliver significant health gains over long periods of time.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	185240
	answer	answer is ministerial correction date of answer 25/05/2023 answer text <p>The National Institute of Health and Care Excellence (NICE) recently carried out a comprehensive review of its methods and processes for health technology evaluation to ensure that they were appropriate to emerging new technologies such as advanced therapeutic medicinal products (ATMPs). NICE published its updated health technology evaluation manual in January 2022 and has introduced a number of changes that ensure that its appraisal processes are suitable for emerging new medicines, including a broader severity modifier and changes to better respond to uncertainty. There are no plans for a further assessment of NICE’s processes for evaluating ATMPs.</p><p> </p><p>NICE’s methods and processes have been proven to be suitable for ATMPs where companies are willing to price their products in a way that represents value to the taxpayer. NICE has recommended 80% of the ATMPs it has evaluated for use by the National Health Service and they are now available for the treatment of NHS patients, including through the Cancer Drugs Fund and managed access agreements negotiated between the NHS and the manufacturer.</p> answering member constituency Colchester answering member printed Will Quince question first answered 25/05/2023 12:35:12 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith